A strategic vision toward global convergence in transplantation must encourage and remove
barriers to living organ donation and transplantation. Here, we discuss deliberations of a …

Living-donor kidney transplantation is the preferred treatment for kidney failure. In the United
States, rates of living kidney donation have been stagnant, which is partly related to …

ABSTRACT Background and Objectives We conducted a national survey to assess the
opinions and experiences of transplant center staff related to processes of care graduation …

The evaluation of living kidney donor candidates is a complex and lengthy process. Donor
candidates face geographic and socioeconomic barriers to completing donor evaluation …

Living kidney and liver donation significantly increase the organ supply to make lifesaving
transplant possible, offering a survival advantage to the recipient and cost savings to the …

Introduction Informational needs and potential use of transplant metrics, especially among
patients, remain understudied and a critical component of the transplant community's …

Introduction Living liver donation improves survival of end‐stage liver disease (ESLD)
patients. Yet, it continues to represent a small proportion of United States (US) liver …

Optimizing the long‐term care and follow‐up of living kidney donors (LKDs) has been
challenging, and prior LKDs have reported suboptimal healthcare experiences. Long‐term …

BACKGROUND Prostaglandin E1 (PGE1), or alprostadil, is a potent vasodilator that
improves hepatic blood flow and reduces ischemia-reperfusion injury post-liver …

Background The number of living kidney donors in the United States has declined since
2005, with variations based on the donor–recipient relationship. The reasons for this decline …